Lataa...
The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real‐world data in Israel
AIMS: Randomized controlled trials have shown that insulin glargine 300 U/mL (Gla‐300) has a more stable and prolonged glucose lowering effect among patients with type 2 diabetes (T2DM) compared to insulin glargine 100 U/mL (Gla‐100), resulting in a reduced risk of hypoglycaemia while maintaining a...
Tallennettuna:
| Julkaisussa: | Endocrinol Diabetes Metab |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7375096/ https://ncbi.nlm.nih.gov/pubmed/32704550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.124 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|